Navamedic ASA (OSL:NAVA)
Norway · Delayed Price · Currency is NOK 16.05
-0.15 (-0.93%)
Jul 15, 2026, 3:33 PM CET
Navamedic ASA Market Cap
Navamedic ASA has a market cap or net worth of 384.9 million as of July 15, 2026. Its market cap has decreased by -5.25% in one year.
Market Cap
384.90M
Enterprise Value
522.54M
Revenue
571.24M
Ranking
n/a
PE Ratio
n/a
Stock Price
16.05
Market Cap Chart
Since March 31, 2006, Navamedic ASA's market cap has increased from 111.70M to 384.90M, an increase of 244.60%. That is a compound annual growth rate of 6.28%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 15, 2026 | 384.90M | -32.56% |
| Dec 30, 2025 | 570.76M | 25.74% |
| Dec 30, 2024 | 453.93M | -28.72% |
| Dec 29, 2023 | 636.85M | 5.92% |
| Dec 30, 2022 | 601.25M | 8.19% |
| Dec 30, 2021 | 555.75M | 90.28% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medistim ASA | 4.15B |
| Nordhealth AS | 1.80B |
| Circio Holding ASA | 1.75B |
| Photocure ASA | 1.57B |
| Lytix Biopharma ASA | 767.46M |
| Omda AS | 740.33M |
| Gentian Diagnostics ASA | 588.97M |
| Zelluna ASA | 579.45M |